These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1723522

  • 1. Bleomycin A2 and B2 purification by flash chromatography for chemical and biochemical studies.
    Freyder CP, Zhou W, Doetsch PW, Marzilli LG.
    Prep Biochem; 1991; 21(4):257-68. PubMed ID: 1723522
    [Abstract] [Full Text] [Related]

  • 2. Chemical and biological properties of bleomycin labelled with 57Co.
    Raban P, Brousil J, Svihovcová P.
    Eur J Nucl Med; 1979 Jun 01; 4(3):191-7. PubMed ID: 91512
    [Abstract] [Full Text] [Related]

  • 3. NMR study of the effects of some bleomycin C-termini on the structure of a DNA hairpin with the 5'-GC-3' binding site.
    Lehmann TE, Murray SA, Ingersoll AD, Reilly TM, Follett SE, Macartney KE, Harpster MH.
    J Biol Inorg Chem; 2017 Jan 01; 22(1):121-136. PubMed ID: 27858165
    [Abstract] [Full Text] [Related]

  • 4. Interactions between bleomycins and metals.
    Nunn AD.
    J Antibiot (Tokyo); 1976 Oct 01; 29(10):1102-8. PubMed ID: 62856
    [Abstract] [Full Text] [Related]

  • 5. Properties of redox-inactivated bleomycins. In vitro DNA damage and inhibition of Ehrlich cell proliferation.
    Templin J, Berry L, Lyman S, Byrnes RW, Antholine WE, Petering DH.
    Biochem Pharmacol; 1992 Feb 04; 43(3):615-23. PubMed ID: 1371685
    [Abstract] [Full Text] [Related]

  • 6. Interaction of Blenoxane and Congeners Bleomycins A2 and B2 with Human Plasma Proteins Using Circular Dichroism Spectroscopy.
    Longo E, Siligardi G, Hussain R.
    Int J Mol Sci; 2023 Sep 02; 24(17):. PubMed ID: 37686404
    [Abstract] [Full Text] [Related]

  • 7. Chemical synthesis of radiolabeled bleomycin A2 and its binding to DNA.
    Roy SN, Orr GA, Brewer CF, Horwitz SB.
    Cancer Res; 1981 Nov 02; 41(11 Pt 1):4471-7. PubMed ID: 6171340
    [Abstract] [Full Text] [Related]

  • 8. High-performance liquid chromatographic determination of components of bleomycin preparations.
    Aszalos A, Crawford J, Vollmer P, Kantor N, Alexander T.
    J Pharm Sci; 1981 Aug 02; 70(8):878-80. PubMed ID: 6171636
    [Abstract] [Full Text] [Related]

  • 9. The separation of hypericine and pseudohypericine from Hypericum perforatum L.
    Smelcerovic A, Laatsch H, Lepojevic Z, Djordjevic S.
    Pharmazie; 2002 Mar 02; 57(3):178-80. PubMed ID: 11933846
    [Abstract] [Full Text] [Related]

  • 10. Amplification of bleomycin-mediated degradation of DNA by polyamines.
    Strekowski L, Mokrosz M, Mokrosz JL, Strekowska A, Allison SA, Wilson WD.
    Anticancer Drug Des; 1988 Aug 02; 3(2):79-89. PubMed ID: 2457380
    [Abstract] [Full Text] [Related]

  • 11. Degradation of DNA and structure-activity relationship between bleomycins A2 and B2 in the absence of DNA repair.
    Moore CW.
    Biochemistry; 1990 Feb 06; 29(5):1342-7. PubMed ID: 1691017
    [Abstract] [Full Text] [Related]

  • 12. Demethylation and auto-oxidation of different cobalt-=bleomycin complexes.
    Vos CM, Schipper D, Herscheid JD, Westera G.
    J Antibiot (Tokyo); 1982 Jul 06; 35(7):837-42. PubMed ID: 6184358
    [Abstract] [Full Text] [Related]

  • 13. Chemical and biologic properties of isolated radiolabeled bleomycin preparations.
    Eckelman WC, Rzeszotarski WJ, Siegel BA, Kubota H, Chelliah M, Stevenson J, Rebra RC.
    J Nucl Med; 1975 Nov 06; 16(11):1033-7. PubMed ID: 52699
    [Abstract] [Full Text] [Related]

  • 14. Proton nuclear magnetic resonances study of bleomycin in aqueous solution. Assignment of resonances.
    Chen DM, Hawkins BL, Glickson JD.
    Biochemistry; 1977 Jun 14; 16(12):2731-8. PubMed ID: 70218
    [Abstract] [Full Text] [Related]

  • 15. Purification of secoisolariciresinol diglucoside with column chromatography on a sephadex LH-20.
    Zhang W, Xu S.
    J Chromatogr Sci; 2007 Apr 14; 45(4):177-82. PubMed ID: 17504564
    [Abstract] [Full Text] [Related]

  • 16. Analytical and biological inequivalence of two commercial formulations of the antitumor agent bleomycin.
    Dorr RT, Meyers R, Snead K, Liddil JD.
    Cancer Chemother Pharmacol; 1998 Apr 14; 42(2):149-54. PubMed ID: 9654115
    [Abstract] [Full Text] [Related]

  • 17. Rapid column separation of bleomycins.
    Shute DJ, Toeg D, Gutteridge JM.
    Med Lab Sci; 1981 Mar 14; 38(2):115-6. PubMed ID: 6175879
    [No Abstract] [Full Text] [Related]

  • 18. Biosyntheses of new bleomycins.
    Fujii A, Takita T, Shimada N, Umezawa H.
    J Antibiot (Tokyo); 1974 Jan 14; 27(1):73-7. PubMed ID: 4135574
    [No Abstract] [Full Text] [Related]

  • 19. [Physicochemical and biological properties of bleomycin complex antibiotics].
    Zenkova VA, Iurina MS, Lomakina NN, Gol'dberg LE, Bazhanov VS.
    Antibiotiki; 1979 Mar 14; 24(3):175-9. PubMed ID: 87144
    [No Abstract] [Full Text] [Related]

  • 20. An improved method for the purification of the trichothecene deoxynivalenol (vomitoxin) from Fusarium graminearum culture.
    Clifford LJ, Jia Q, Pestka JJ.
    J Agric Food Chem; 2003 Jan 15; 51(2):521-3. PubMed ID: 12517120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.